Alpha Tau Medical (DRTS) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Alpha Tau Medical (DRTS) is Neutral.

The composite score behind that read is -0.08, weighing +0.24 of bullish evidence against -0.29 bearish.

Alpha Tau Medical last closed at $14.89, +0.81% on the session.

Against the IVW growth benchmark the position is -0.11% over the forecast window.

The read is built from 13 underlying insights — 4 bullish and 9 bearish.

Agreement across those insights is 69%.

Alpha Tau Medical has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Alpha Tau Medical in the 8th percentile on return on equity, where 100 is best.

Alpha Tau Medical is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $1.37B.

StockMap tracks Alpha Tau Medical as the 53rd largest of the 133 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 67 Neutral, 61 Moderate Underperform, 4 Strong Underperform and 1 Moderate Outperform.

On that composite Alpha Tau Medical ranks 26th of 133 in the group, against a group median of -0.21.